NCT03794310 - Study of NPF-08 in Patients Who Receive Colonoscopy | Biotech Hunter

Enrollment

632

Participants

Timeline

Start Date

January 5, 2019

Primary Completion Date

June 19, 2019

Study Completion Date

June 19, 2019

Conditions

Patients Who Receive Colonoscopy

Interventions

DRUG

NPF-08 （1-day treatment）

NPF-08 will be administered on the day of colonoscopy.

DRUG

NPF-08 （2-day split dose）

NPF-08 will be administered at 2 days divided into the day before and on the day of colonoscopy.

DRUG

Moviprep（1-day treatment）

Moviprep will be administered on the day of colonoscopy.

Trial Locations (13)

NPF-08 Trial Site 12, Abiko

NPF-08 Trial Site 11, Kashiwa

NPF-08 Trial Site 1, Maebashi

NPF-08 Trial Site 10, Kawasaki

NPF-08 Trial Site 5, Yokohama

NPF-08 Trial Site 9, Yokohama

NPF-08 Trial Site 2, Chuo-Ku

NPF-08 Trial Site 3, Minato-Ku

NPF-08 Trial Site 4, Shinjuku-Ku

NPF-08 Trial Site 8, Hiroshima

NPF-08 Trial Site 13, Kouchi

NPF-08 Trial Site 6, Osaka

NPF-08 Trial Site 7, Osaka